Piotr Stepien
About Piotr Stepien
Piotr Stepien is a Research Scientist specializing in In Vitro Pharmacology, currently employed at Exscientia in Oxford, England. He has previously held positions at Selvita and has academic experience from institutions such as Dana-Farber Cancer Institute and the University of Oxford.
Work at Exscientia
Piotr Stepien has been employed at Exscientia as a Research Scientist specializing in In Vitro Pharmacology since 2021. His role involves conducting research that contributes to the development of new therapeutic agents. Exscientia is known for its innovative approach to drug discovery, utilizing artificial intelligence to enhance the efficiency of the research process. Stepien's work supports the company's mission to transform the way drugs are developed.
Previous Experience at Selvita
Prior to his current position, Piotr Stepien worked at Selvita, where he held multiple roles. He began as a Research Assistant for three months in 2017. He then progressed to Scientist I from 2018 to 2020, and later served as Scientist II from 2020 to 2021. During his tenure at Selvita, he contributed to various research projects focused on drug discovery and development, enhancing his expertise in pharmacology.
Education and Expertise
Piotr Stepien earned his Magister (Mgr) degree in Biotechnologia Medyczna from Śląska Akademia Medyczna w Katowicach, studying from 2015 to 2017. He also holds a Licencjat (Lic.) in Biotechnologia from Uniwersytet Marii Curie-Skłodowskiej w Lublinie, where he studied from 2012 to 2015. His educational background provides a strong foundation in biotechnology and pharmacology, which he applies in his research endeavors.
Research Experience at Dana-Farber Cancer Institute
In 2017, Piotr Stepien worked as a Visiting Master Student at Dana-Farber Cancer Institute for six months. This experience allowed him to engage in advanced cancer research, further developing his skills in pharmacology and laboratory techniques. His time at Dana-Farber contributed to his understanding of the complexities involved in cancer treatment and drug development.
Visiting Master Student at University of Oxford
In 2016, Piotr Stepien was a Visiting Master Student at the University of Oxford for one month. This opportunity provided him with exposure to cutting-edge research and methodologies in the field of biotechnology. His experience at such a prestigious institution has likely influenced his approach to research and development in his subsequent roles.